Article metrics

Download PDFPDF

218 A preclinical study of IMC-002, a fully human therapeutic antibody safely targeting CD47 in cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020164019
Dec 202044010
Jan 20214107
Feb 20215209
Mar 2021152043
Apr 202168012
May 202114015
Jun 20210012
Jul 20210013
Aug 2021007
Sep 2021009
Oct 2021104024
Nov 2021128045
Dec 20218409
Jan 20225809
Feb 202224011
Mar 202260014
Apr 202290014
May 202254011
Jun 202262014
Jul 202250011
Aug 2022110019
Sep 20222202
Oct 20223408
Nov 20223208
Dec 202250014
Jan 20235008
Feb 202368012
Mar 20233607
Apr 20234608
May 20232803
Jun 20233603
Jul 202388015
Aug 20234202
Sep 20233803
Oct 20237409
Nov 2023106012
Dec 20235807
Jan 20244602
Feb 20245402
Mar 202446014
Apr 20242406
May 20242200
Jun 20246408
Jul 20243408
Aug 20246206
Sep 20246204
Oct 202474023
Nov 202482010
Dec 202430015
Jan 202544012
Feb 202510015
Mar 2025007
Apr 20250010
May 20250012
Jun 2025006
Total28210618